Rapid Risk Assessment: invasive meningococcal disease among men who have sex with men
This rapid risk assessment provides a series of conclusions and recommendations based on the analysis of several European cases of invasive meningococcal disease among men who have sex with men caused by N. meningitidis serogroup C.
Rapid Risk Assessment: Outbreak of invasive meningococcal disease in the EU associated with a mass gathering event in Japan, 21 August 2015
This rapid risk assessment considers the risk to the EU of an outbreak of invasive meningococcal disease in the UK and Sweden associated with the 23rd World Scout Jamboree in Japan.
Risk assessment guidelines for infectious diseases transmitted on aircraft
In the closed cabin environment of modern airplanes, passengers are frequently exposed to various infectious diseases. This report looks at 12 infectious diseases and, by systematically evaluating literature on on-board transmission, attempts to assess the risk of infection via air circulation in airplanes.
These guidelines are complemented by operational guidelines in relation to tuberculosis, new emerging airborne diseases (e.g. SARS) and meningococcal infections.
Risk assessment guidelines for diseases transmitted on aircraft (RAGIDA) - Part 2: Operational guidelines for assisting the evaluation of risk for transmission by disease
Public health guidance on management of sporadic cases of invasive meningococcal disease and their contacts
The purpose of this document is to provide evidence-based guidance for good practice in public health management of sporadic cases of meningococcal disease and their contacts.
Systematic review on the incubation and infectiousness/shedding period of communicable diseases in children
Illnesses caused by infectious diseases are common in children in schools or other childcare settings. Currently there is no common EU approach to the control of communicable diseases in schools or other childcare settings, and existing information is uncertain.
Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA
This expert opinion is intended to support national decision-making by summarising the considerations and concerns of some EU/EEA countries when they discussed whether to introduce the 4CMenB vaccine into their national immunisation programmes.